Press Releases

07.05.2011

Cell Signaling Technology, Inc. Grants a Patent License to Pfizer

06.14.2011

pSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device in Ocular Hypertension and Glaucoma

06.09.2011

Lpath Granted 22nd Patent Related to Lipidomics-Based Drug Development Program

06.02.2011

Pfizer and Hisun Sign MOU to Increase Access to Quality and Low-Cost Medicines for Patients in China

06.02.2011

Clovis Oncology, Inc. Receives License for Worldwide Development and Commercialization Rights to Pfizer’s Oral and IV PARP Inhibitor PF-01367338

05.10.2011

Foundation for the NIH Launches Trial to Develop Diabetes Diagnostic Tools

05.10.2011

Cellzome to Study Epigenetic Factors with Neusentis

05.09.2011

Staphylococcus aureus Investigational Vaccine Elicits a Positive Immune Response in Phase 1 Study

05.04.2011

Oxford BioMedica Broadens 5T4 Antibody Collaboration With Pfizer

04.07.2011

Zacharon Pharmaceuticals Announces Research and Development Collaboration with Pfizer to Develop Drugs for Multiple Rare Disorders

04.04.2011

Rigel Assumes Development Responsibility

04.04.2011

Pfizer to Sell Capsugel to KKR